Guided Self-Help Treatment for Binge Eating Disorder (BEST)
|Eating Disorders Bulimia||Behavioral: Guided self-help cognitive behavioral therapy (CBT) Behavioral: Usual clinical care|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Binge Eating Self-Guided Treatment (BEST)|
- Frequency of binge eating [ Time Frame: Measured at post-treatment, Week 12, Month 6, and Year 1 ]
- Frequency of inappropriate compensatory behaviors, dietary restraint, over-valuation of weight/shape, functional impairment, self-esteem, and social impairment [ Time Frame: Measured at post-treatment, Week 12, Month 6, and Year 1 ]
- Body weight [ Time Frame: Measured at post-treatmentand Year 1 ]
|Study Start Date:||August 2004|
|Study Completion Date:||July 2008|
|Primary Completion Date:||July 2008 (Final data collection date for primary outcome measure)|
Participants will receive guided self-help cognitive behavioral therapy
Behavioral: Guided self-help cognitive behavioral therapy (CBT)
Participants receive eight sessions of guided self-help CBT.
Active Comparator: 2
Participants will receive treatment as usual
Behavioral: Usual clinical care
Control group participants receive treatment as usual.
Binge eating disorder (BED) is a serious condition characterized by compulsive overeating and feelings of powerlessness. The condition often has a negative impact on both physical and emotional health. This study will examine ways to help people determine whether they have BED and will test whether guided self-help (GSH) treatment is effective in treating BED.
Participants will be randomly assigned to receive either GSH treatment or usual clinical care (which may include general support and talk therapy) for 3 months. The GSH treatment is a cognitive behavioral therapy-based program that will be administered over 8 sessions. Participants receiving GSH will be given a book that focuses on dealing with BED; they will also meet with a therapist regularly to have their progress monitored. The Eating Disorders Examination (EDE), self-reports, questionnaires, and surveys will be used to assess participants. Assessments will be conducted at study entry, at Weeks 2 and 4 of the treatment, at the end of the treatment, and at 6 and 12 months post-treatment.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00158340
|United States, Connecticut|
|Wesleyan University Department of Psychology|
|Middletown, Connecticut, United States, 06459|
|United States, Oregon|
|Kaiser Permanente Center for Health Research|
|Portland, Oregon, United States, 97227|
|Principal Investigator:||Ruth H. Striegel-Moore, PhD||Wesleyan University|